Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
36.33
-0.56 (-1.52%)
At close: Mar 25, 2026, 4:00 PM EDT
36.50
+0.17 (0.47%)
After-hours: Mar 25, 2026, 7:59 PM EDT
Novo Nordisk (NVO) Operating Income by Segment
History
| Date | Diabetes and Obesity Care | Rare Disease |
|---|---|---|
| Sep 30, 2025 | 20.42B | 188.78M |
| Jun 30, 2025 | 21.86B | 326.91M |
| Mar 31, 2025 | 20.94B | 83.28M |
| Dec 31, 2024 | 19.84B | 96.33M |
| Sep 30, 2024 | 18.29B | 102.70M |
| Jun 30, 2024 | 17.24B | 78.31M |
| Mar 31, 2024 | 16.58B | 424.96M |
| Dec 31, 2023 | 15.48B | 458.52M |
| Sep 30, 2023 | 14.07B | 360.32M |
| Jun 30, 2023 | 12.74B | 645.28M |
| Mar 31, 2023 | 11.68B | 853.02M |
| Dec 31, 2022 | 10.47B | 1.15B |
| Sep 30, 2022 | 9.68B | 1.41B |
| Jun 30, 2022 | 8.88B | 1.44B |
| Mar 31, 2022 | 8.30B | 1.45B |
| Dec 31, 2021 | 7.70B | 1.41B |
| Sep 30, 2021 | 7.27B | 1.46B |
| Jun 30, 2021 | 6.76B | 1.60B |
| Mar 31, 2021 | 6.64B | 1.56B |
| Dec 31, 2020 | 6.80B | 1.61B |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.